|
|
|
| calgb.org > CALGB Web Site Home |
|
| Welcome to the Cancer and Leukemia Group B Web Site |
The Cancer and Leukemia Group B (CALGB) is a national clinical research group sponsored by the National Cancer Institute, with its Central Office headquartered at the University of Chicago and its Statistical Center located at Duke University. The CALGB was founded in 1956 with a goal of bringing together clinical oncologists and laboratory investigators to develop better treatments for cancer. Since 1956, CALGB has grown into a national network of 26 university medical centers, over 225 community hospitals and more than 3000 oncology specialists who collaborate in clinical research studies aimed at reducing the morbidity and mortality from cancer, relating the biological characteristics of cancer to clinical outcomes and developing new strategies for the early detection and prevention of cancer. [continued]
|
| CALGB News |
Fall 2008 Issue of CAL-GAB Newsletter Now Available
Full Text
Spring 2008 Issue of CAL-GAB Newsletter Now Available
Full Text
Winter 2007 Issue of CAL-GAB Newsletter Now Available
Full Text
2007 CALGB Central Office and Statistical Center Registration/Randomization and Specimen Repositories Holiday Schedules
Full Text
Fall 2007 Issue of the CAL-GAB Newsletter Now Available
Full Text
Main
| Next page >
|
| CALGB Foundation |
The Cancer and Leukemia Group B Foundation is a nonprofit, tax-exempt foundation formed for the primary purpose of aiding the Cancer and Leukemia Group B national clinical trials cooperative group. The CALGB Foundation supports the clinical trials and laboratory research of the CALGB, as well as efforts to educate the medical community on methods of cancer diagnosis, treatment, and prevention. Recent initiatives supported by the CALGB Foundation:
- New chemotherapy treatments for breast, prostate, lung and colorectal cancer.
- New surgical techniques for breast and colon cancer.
- Genetic studies of breast cancer risk.
- Molecular determinants of response to therapy for breast, colorectal and lung cancer as well as leukemia.
- Improving the quality of life of cancer patients and their caregivers.
|
|
|
|
|
|
|
